Statement: maternal half sibling is a relative with whom you share a biological mother but you have different fathers. the primary trial and the secondary trial participants do not receive any medication orally.
Primary_evidence: INTERVENTION 1:    Intraductal Arm   Participants received intraductal administration of dextrose or dextrose with pegylated liposomal doxorubicin hydrochloride (or PLD) prior to conventional surgery for breast cancer.
Secondary_evidence: INTERVENTION 1:    Cetuximab   Patients receive cetuximab IV over 60-120 minutes once a week. Treatment repeats every 28 days in the absence of disease progression or unacceptable toxicity. Patients not responding to treatment may cross over to arm II.   cetuximab: Given IV INTERVENTION 2:    Cetuximab and Carboplatin After Cetuximab Alone   Patients from Arm 1 who progressed on cetuximab alone who went on to receive cetuximab + carboplatin